Abstract: According to an exemplary embodiment of the present disclosure, disclosed is an aluminum coated blank that includes a first coated steel sheet; a second coated steel sheet connected to the first coated steel sheet; and a joint portion that connects the first coated steel sheet to the second coated steel plate at a boundary between the first coated steel sheet and the second coated steel sheet.

Abstract: An apparatus and method for manufacturing a grilled seaweed includes the apparatus comprising a grilling unit having a first housing with a first inlet opening and a first outlet opening which communicate with each other; a first conveyor for transferring a sheet of seaweed from the first inlet opening to the first outlet opening; a first heating source installed over the first conveyor to discharge a flame onto a top surface of the seaweed being transferred by the first conveyor; and a second heating source installed on both sides of a lower portion of the first conveyor to apply a flame onto a bottom surface of the seaweed being transferred by the first conveyor.

Abstract: Disclosed are a controlled-release dosage form with an absorption window in the upper gastrointestinal tract and a preparation method therefor, wherein the controlled-release dosage form comprises a controlled-release platform and a retention platform. The controlled-release platform is a pharmaceutical composition comprising a tablet core and a coating membrane; and the retention platform holds the controlled-release platform in the oral cavity. The operation steps of the controlled-release dosage form are as follows: placing the controlled-release platform in the retention platform, and fixing the retention platform on matching teeth in the oral cavity; taking out the controlled-release dosage form after 4-24 hours and replacing same with a new controlled-release platform; and re-fixing the retention platform on the matching teeth in the oral cavity to achieve the sustained and stable release of drugs.

Abstract: Disclosed is a pharmaceutical composition containing dabigatran etexilate and a preparation method thereof. The pharmaceutical composition comprises a pharmaceutically active ingredient, dabigatran etexilate and/or dabigatran etexilate mesylate, an amphiphilic polymer of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer, and a hydrophilic polymer of polyoxyethylene-polyoxypropylene glycol block copolymer. The mass percentage of the active pharmaceutical ingredient in the pharmaceutical composition is 5 wt % to 60 wt %; the mass percentage of the amphiphilic polymer in the pharmaceutical composition is 3 wt % to 40 wt %; and the mass percentage of the hydrophilic polymer in the pharmaceutical composition is 10 wt % to 90 wt %. The pharmaceutical composition not only increases the bioavailability of the pharmaceutically active ingredient, but also reduces absorption variability, and provides a more stable concentration of dabigatran in plasma, thereby reducing adverse side effects.

Abstract: A solid particle, a preparation method therefor, and a pharmaceutical composition. The solid particle comprises a porous solid particle and a non-aqueous liquid formula. The non-aqueous liquid formula comprises 0.10-4.00 wt % of a hydrophobic active pharmaceutical agent, 28.00-99.90 wt % of a hydrophobic solubilizing solution, 0-70.00 wt % of a non-ionic surfactant, and 0-1.00 wt % of an antioxidant. The hydrophobic solubilizing solution comprises a medium-chain monoglyceride and diglyceride, and/or a propylene glycol fatty acid monoester.

Abstract: Disclosed are a pharmaceutical composition, an osmotic pump controlled-release drug delivery system comprising the pharmaceutical composition and a preparation method therefor. The pharmaceutical composition comprises a tablet core and a coating film. The tablet core comprises a drug-pulling layer, and the coating film comprises 50-90 wt % of cellulose acetate and 10-50 wt % of Copovidone. The Copovidone can be obtained by means of the polymerization of vinyl pyrrolidone and vinyl acetate in a molar ratio of 40:60-80:20.

Abstract: Disclosed is a pharmaceutical composition containing dabigatran etexilate and a preparation method thereof. The pharmaceutical composition comprises a pharmaceutically active ingredient, dabigatran etexilate and/or dabigatran etexilate mesylate, and a amphiphilic polymer of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer. The mass ratio of the two is 1:0.23 to 1:3. The pharmaceutical composition not only increases the bioavailability of the pharmaceutically active ingredient, but also reduces absorption variability, and provides a more stable concentration of dabigatran in plasma, thereby reducing adverse side effects.

Abstract: The present invention relates to a noninvasive electrical stimulation method and device, and the noninvasive electrical stimulation method includes the steps of: arranging first and second electrodes for applying electrical stimulation to a human body and first and second magnetic materials to thus allow the first and second magnetic materials to generate a magnetic field in a direction crossing the direction of an electric current between the first and second electrodes; and controlling at least one of a crossing angle (?) at which the electric current between the first and second electrodes and the magnetic field generated by the first and second magnetic materials cross each other and the strength (B) of the magnetic field generated by the first and second magnetic materials.

Abstract: An apparatus and a method for the disclosure relates to an artificial intelligence (AI) system that simulates functions such as recognition and determination of the human brain by using a machine training algorithm such as deep learning and an application of the AI system are provided. A neural network training method includes obtaining target modality signals of a first domain aligned in a time order and auxiliary modality signals of a second domain that are not aligned in the time order, extracting characteristic information of the target modality signals using a first neural network model, estimating the time order of the auxiliary modality signals using a second neural network model, and training the first neural network model based on a result of the estimation and the characteristic information.

Abstract: A bioreactor sensing system is presented. The bioreactor sensing system comprises a bioreaction vessel. The bioreaction vessel comprises an aperture configured to provide an interface for monitoring contents within the bioreaction vessel. The bioreaction vessel also comprises a port coupled to the bioreaction vessel proximate the aperture. The bioreactor sensing system also comprises a sensing device disposed at least partially within the port such that a sensing element is exposed to the contents. The bioreactor sensing system also comprises an external seal configured to be applied over a portion of the sensing device and a portion of the port.

Abstract: The present disclosure discloses a method for making an ice surface of an ice rink and an ice rink including the ice surface. In the method, a salt solution is applied to an ice surface. The salt solution contains anions. A concentration of the anions is in a range from about 0.63 mmol/L to about 10 mmol/L. The anions in the salt solution are selected from the group consisting of chloride ions, nitrate ions, bromide ions, iodide ions, chlorate ions, perchlorate ions, thiocyanate ions, and any combination thereof. The ice surface is maintained at a temperature of about ?4° C. to about 14° C. to naturally freeze the salt solution.

Abstract: A display module, a display system, a control method for the display system are provided. The display module includes: a backlight module including an optical film; two display panels on a light exiting side of the optical film, where the two display panels are adjacent to each other and are spliced, orthographic projections of the two display panels onto a plane where the optical film is located are within the optical film, and the orthographic projections of the two display panels onto the plane where the optical film is located do not overlap; and a transparent cover plate on light exiting sides of the display panels, where an ink layer is arranged on a side of the transparent cover plate facing the backlight module, and the ink layer covers a region between two adjacent display panels.

Abstract: The present invention states a method of producing new cathode materials for lithium ion batteries by recycling metals from depleted lithium-ion batteries using green reagents, and a method of deriving green reagents from agricultural products. The green reagents are used to replace corrosive acids that are used in the recycling process of depleted lithium-ion batteries. Metal ions, such as nickel, cobalt, manganese, and lithium are recovered as precipitates from the depleted lithium-ion batteries which can further be sintered to produce lithium-containing transition metal oxides that can be used as new cathode material for lithium-ion batteries.

Abstract: The invention encompasses biodegradable compositions (e.g., biodegradable plastics) and methods of preparation and use thereof, and disposable products made from the claimed compositions. Raw materials for preparing the biodegradable plastic include one or more polymers, fiber, starch, a plasticizer, and a coupling agent. The biodegradable composition has the advantages of short degradation cycle, good mechanical properties, and a low manufacturing cost.

Abstract: A drug accommodating device of a solid oral formulation and an oral administration and delivery apparatus comprising same. The drug accommodating device comprises a filtering component and a supporting component; the filtering component and the supporting component cooperate with each other to form a space used for bearing drug particles or multiple pills; the filtering component has one or more pore channels allowing a liquid to pass; the pore channels are distributed in the filtering component in an up-down intricate intersection mode; alternatively, a water-soluble polymer material layer is provided on the filtering component.

Abstract: A display module, a display system, a control method for the display system are provided. The display module includes: a backlight module including an optical film; two display panels on a light exiting side of the optical film, where the two display panels are adjacent to each other and are spliced, orthographic projections of the two display panels onto a plane where the optical film is located are within the optical film, and the orthographic projections of the two display panels onto the plane where the optical film is located do not overlap; and a transparent cover plate on light exiting sides of the display panels, where an ink layer is arranged on a side of the transparent cover plate facing the backlight module, and the ink layer covers a region between two adjacent display panels.

Abstract: A bioreactor vessel is provided. The bioreactor vessel comprises a bioreactor bag wall having an interior side and an exterior side and an aperture extending from the interior side to the exterior side, wherein the interior side is configured to contact and house a reaction mixture. The bioreactor vessel also comprises a port mounted proximate the aperture, the port including a flange fixedly attached to the bioreactor bag, such that a fluidic seal is maintained along a circumference of the flange. The bioreactor vessel also comprises a plurality of sensors disposed within the port.

Abstract: A backlight module, a display module, and a display device are provided in the present disclosure, which belong to the technical filed field of display devices. A display device includes a light guide plate and a light-shielding member. The light guide plate includes a light exiting surface and a bottom surface that are oppositely arranged, and a light incident surface and a light shielding surface both connected with the light exiting surface and the bottom surface. The light shielding member is disposed on the light shielding surface, where the light-shielding member includes a light reflecting layer and a light absorbing layer, and the light-absorbing layer is located on a side of the light reflecting layer away from the light shielding surface.

Abstract: A sensor may include a sensing element retained within a storage compartment filled with a storage medium, which may also be used as a calibration medium. The sensing element can include a sensing surface located away from the distal end of the sensing element, such that an inactive section of the sensing element can cooperate with a sealing member such as an O-ring to form part of the seal retaining the storage/calibration medium. The sensing element can be extended and retracted from the storage compartment to expose the sensing surface to a process medium, while preserving the storage medium within the storage compartment for post-measurement validation.

Abstract: A sensor may include a sensing element retained within a storage compartment filled with a storage medium, which may also be used as a calibration medium. The sensing element can be moved from a first position in which the sensing element is exposed to the storage compartment, and a second position in which the sensing element can be exposed to a process medium. An actuator mechanism may be configured to engage a portion of the sensor to move the sensing element between the first position and the second position. The actuator mechanism may be controlled by an external system, and may include a rotary actuator such as a servomotor or a stepper motor to move the sensing element between the first position and the second position.